Desai & Diwanji advise Sanofi Pasteur in Shanta Biotechnics acquisition
Bar&Bench News Network
Aug 26, 2009
Desai & Diwanji continues to strengthen its Mergers and Acquisitions practice, advising on a whopping Rs. 3,748 crore ($781 million) deal. Desai and Diwanji advised French pharma major Sanofi Pasteur in their acquisition of Hyderabad based Shanta Biotechnics.
Sanofi Pasteur acquired Merieux Alliance's French subsidiary, ShanH, which has a 78 percent stake in Shanta Biotechnics. The Desai & Diwanji team comprising Devika Cariappa and Ketaki Gaur were led by Partner Apurva Diwanji.
|
 |
Be the first to post a comment 
Post Your Comment
Other Deal Street
- AZB and Indus lead on Warburg Pincus $32 million investment in Quickr
- Khaitan, Kochhar and Crawford help Oriental Carbon and Chemicals buy 50% stake in Schrader Duncan JV
- AZB and NDA advise on Genpact’s acquisition of Atyati Technologies
- AZB and Sidley Austin help Kae Capital raise funds
- Amarchand and Weil Gotshal lead on Piramal Healthcare’s acquisition of US-based Decision Resources Group
- AZB, DLA and JSA help Dutch Manager APG to invest Rs. 650 crore in Lemon Tree Hotels
- Amarchand and Desai Diwanji help Nagpur Automotive acquire Adhunik Metalik’ forging subsidiary
Top News
- Re-Upped Round up May 23
- Alternative Law Forum to hold 2 day course on ‘Free Speech law in India’
- BCI to start Phase-Wise Agitation to oppose Higher Education Bill; July 11 and 12 to be Protest Days; Dharna at Jantar mantar in August
- End of Venture Capital Fund Regulations; SEBI notifies Alternate Investment Fund Regulations
- SILF supports Nariman for President of India; Says no one knows the working of the Constitution better
- Re-Upped Round up May 22
- Supreme Court Lawyers Welfare Trust encourages young talent; Introduces 2 annual fellowships
Webmasters: AIKYA